Aspirin use for cardiovascular disease may reduce likelihood of COVID-19 infection, study finds

In a recent study, aspirin use to avoid the development of cardiovascular diseases in healthy individuals was associated with a 29 percent lower likelihood of COVID-19 infection, as compared to aspirin non-users. The proportion of patients treated with aspirin was significantly lower among the COVID-19-positive individuals, as compared to the COVID-19-negative ones. And those subjects who had been treated with aspirin were less associated with the likelihood of COVID-19 infection than those who were not. View original article here Source

Related Posts